fbpx
Friday, April 16, 2021
Coronavirus variant that spreads easily doesn’t do so by surviving in air better

Coronavirus variant that spreads easily doesn’t do so by surviving in...

Enlarge / People practice social distancing in white circles in Domino Park in Williamsburg during the coronavirus pandemic on May 17, 2020, in New York City. Covid-19 Coverage View more stories The B.1.1.7 coronavirus variant is estimated to spread about 50 percent more than previous versions—but it doesn’t seem to manage that higher transmissibility by…
Real-world data shows vaccines kicking butt—including against scary variant

Real-world data shows vaccines kicking butt—including against scary variant

Enlarge / A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine inside the Viejas Arena on the campus of San Diego State University in San Diego, California, US on Thursday, April 1, 2021. Covid-19 Coverage View more stories In a small trial, the Pfizer/BioNtech vaccine fully protected people from symptomatic COVID-19 caused by…
Factory mix-up spoils 15 million doses of J&J COVID vaccine

Factory mix-up spoils 15 million doses of J&J COVID vaccine

Enlarge / A sign at the Johnson & Johnson campus on August 26, 2019 in Irvine, California. Covid-19 Coverage View more stories About 15 million doses of Johnson & Johnson’s one-shot COVID-19 vaccine were ruined, and future vaccine shipments will be delayed. This all follows a mix-up at a manufacturing facility in Baltimore, according to…
Trial started for vaccine against one of the scariest coronavirus variants

Trial started for vaccine against one of the scariest coronavirus variants

Enlarge / A vial of the current Moderna COVID-19 vaccine. Covid-19 Coverage View more stories Researchers have given out the first jabs of a tweaked version of Moderna’s COVID-19 vaccine, one aimed at fighting one of the most concerning coronavirus variants—the B.1.351 variant, first identified in South Africa. The jabs are part of an early…
Teens fully protected by Pfizer’s COVID-19 vaccine, company says

Teens fully protected by Pfizer’s COVID-19 vaccine, company says

0
Enlarge / Jonathan, a 16-year-old teenager, receives a dose of the Pfizer-BioNtech COVID-19 coronavirus vaccine at Clalit Health Services, in Israel's Mediterranean coastal city of Tel Aviv on January 23, 2021. Adolescents ages 12 to 15 were completely protected from symptomatic COVID-19 after being vaccinated with the Pfizer/BioNTech mRNA vaccine in a small Phase III…
Experts sound alarm of possible new COVID surge as US cases once again rise

Experts sound alarm of possible new COVID surge as US cases...

0
Enlarge / A health advisory sign on a beach in Florida. Covid-19 Coverage View more stories In mid-January, US cases of COVID-19 were in a nosedive from a towering record of over 315,000 new cases in a single day earlier in the month. And now, the pace of vaccinations has reached a heartening clip of…
Authorities raise red flags about AstraZeneca’s vaccine press release [Updated]

Authorities raise red flags about AstraZeneca’s vaccine press release [Updated]

0
Update 4 pm EDT: The board of experts monitoring the clinical trial of AstraZeneca’s COVID-19 vaccine determined that the vaccine is actually between 69 percent and 74 percent effective at preventing symptomatic disease—not 79 percent effective, as AstraZeneca announced Monday. According to a report by The Washington Post, the trial’s Data and Safety Monitoring Board…
AstraZeneca vaccine: 79% effective and no rare blood clots in US trial

AstraZeneca vaccine: 79% effective and no rare blood clots in US...

0
Enlarge / Vials of the AstraZeneca COVID-19 vaccine are seen during the opening of a vaccination center in Cyprus, on March 22, 2021. Covid-19 Coverage View more stories Exceeding expectations, AstraZeneca’s two-dose COVID-19 vaccine appeared highly effective against symptomatic and severe disease in a new late-stage trial conducted partly in the US. The company said…
Under pressure, CDC drops school spacing to 3 ft in many classrooms

Under pressure, CDC drops school spacing to 3 ft in many...

0
Enlarge / Rochelle Walensky, director of the US Centers for Disease Control and Prevention (CDC), adjusts her protective mask during a Senate Health, Education, Labor, and Pensions Committee hearing in Washington, DC. Susan Walsh/AP/Bloomberg via Getty Images Covid-19 Coverage View more stories With universal masking, just 3 feet of distancing is safe for students in…
Many Republicans are refusing COVID vaccines. Experts are trying to change that

Many Republicans are refusing COVID vaccines. Experts are trying to change...

0
Enlarge / A Donald Trump supporter holds an false anti-vaccine sign while protesting in Washington, DC, on Tuesday, Jan. 5, 2021. Covid-19 Coverage View more stories While the Biden administration anticipates having enough COVID-19 vaccine doses to vaccinate all adults by May 1, health experts and policy advisors are trying to figure out how to…

Recent Posts